Chinook Therapeutics, Inc. Profile Avatar - Palmy Investing

Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin recepto…
Biotechnology
US, Seattle [HQ]
Major Shareholders · Outstanding & Floating · Short Interest

Share Analysis

Breakdown
Chinook Therapeutics, Inc. can't present any analysts estimates at the moment detail analysis.
Short
Fail To Deliver
Not available for KDNY
Shorts Over Time
Not available for KDNY
Latest Settlement
Settlement Date n/a
Short Volume $n/a
Change n/a
Short Float n/a
Change n/a
Days to Cover n/a
Change n/a